Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed…
Why Are Men More Vulnerable to COVID-19? Research Is Gradually Uncovering the Truth
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health,…
To Do the Therapy & MRI Follow-up or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board…
To Do the Surgery or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices…
Antibody Testing May Not Give You the Back-to-Work Safety Pass as Expected
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With a phased reopening starting..
